Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_3
9
90%

Phase Distribution

0

Early Stage

0

Mid Stage

9

Late Stage

Phase Distribution10 total trials
Phase 3Large-scale testing
9(90.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(10)

Detailed Status

Completed10

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 39 (90.0%)
N/A1 (10.0%)

Trials by Status

completed10100%

Recent Activity

0 active trials
Showing 5 of 10
completedphase_3

Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

NCT00063206
completedphase_3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

NCT00073762
completedphase_3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

NCT00075257
completednot_applicable

Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

NCT00242229
completedphase_3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

NCT00072774
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00063206Phase 3

Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

Completed
NCT00073762Phase 3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Completed
NCT00075257Phase 3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Completed
NCT00242229Not Applicable

Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder

Completed
NCT00072774Phase 3

Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

Completed
NCT00087737Phase 3

Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder

Completed
NCT00092911Phase 3

Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

Completed
NCT00090649Phase 3

Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder

Completed
NCT00421031Phase 3

Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause

Completed
NCT00256685Phase 3

Study Evaluating DVS-233 SR to Treat Vasomotor Systems Associated With Menopause

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10